The survival rate of tuberculosis patients in HIV-treated cohort of 2008-2018 in Almaty, Kazakhstan

Authors

  • Ainur Zhandybayeva Almaty City Center of Prevention and Control of AIDS, Almaty, Kazakhstan
  • Nune Truzyan FMD KL Europe, Yerevan, Armenia
  • Elina Shahumyan FMD KL Europe, Yerevan, Armenia
  • Aizat Kulzhabaeva USAID Defeat TB Project in Kyrgyz Republic, Bishkek, Kyrgyzstan
  • Zhamilya Nugmanova Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
  • Alfiya Denebayeva Almaty City Center of Prevention and Control of AIDS, Almaty, Kazakhstan
  • Marat Tukeyev Almaty City Center of Prevention and Control of AIDS, Almaty, Kazakhstan

DOI:

https://doi.org/10.3855/jidc.11955

Keywords:

tuberculosis, HIV, survival, SORT IT

Abstract

Introduction: HIV/TB comorbidity is responsible for 1.6 million deaths worldwide. HIV/TB control and patients’ survival are still among priorities of the national HIV and TB programs. We aimed to evaluate the HIV/TB survival in connection with TB treatment outcomes and factors influencing life duration of the cohort 2008-2018 in Almaty, Kazakhstan.

Methodology: This retrospective cohort study extracted data for all HIV and pulmonary TB adults coinfected during 2008-2018 in Almaty from national registries to apply descriptive, Kaplan-Meier estimation, and Cox proportional hazards regression model. Survival function for the TB treatment outcomes and factors predicting the probability of survival were tested and described.

Results: The cohort population (n = 521) mean age was 37.4 years with 405 (77.7%) males and 210 (40.3%) marrieds. More than one TB treatment had 181 (34.7%) patients, 291 (55.9%) were smear-positive (SS+), and 423 (81.2%) were on antiretroviral therapy with mean CD4 count 254.22cells/µL. Probability to live longer was higher (128 versus 37 months, p = 0.003; 95% confidence interval (CI) 71.65, 184.35) for those who succeeded in TB treatment compared to “lost to follow-up” and “failed” treatment outcomes. Adjusted Cox regression model death hazard showed association with missing ART treatment (HR: 1.699, 95%CI 1.164, 2.481, p = 0.006) and having CD4 count < 499 (HR 2.398, 95%CI 1.191, 4.830, p < 0.014).

Conclusion: TB treatment outcomes, ART treatment, and the CD4 count of HIV/TB coinfected population substantially influence their life duration. The medical decision- and policy-makers should take this into consideration when implementing targeted improvements in the national HIV and TB programs.

Downloads

Published

2020-11-16

How to Cite

1.
Zhandybayeva A, Truzyan N, Shahumyan E, Kulzhabaeva A, Nugmanova Z, Denebayeva A, Tukeyev M (2020) The survival rate of tuberculosis patients in HIV-treated cohort of 2008-2018 in Almaty, Kazakhstan. J Infect Dev Ctries 14:116S-121S. doi: 10.3855/jidc.11955

Issue

Vol. 14 No. 11.1: November 2020 -- SUPPLEMENT

Section

SORT IT TB Key Population

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC